<DOC>
	<DOCNO>NCT01507168</DOCNO>
	<brief_summary>This randomize , placebo-controlled , multicenter study evaluate efficacy safety RO5137382 ( GC33 ) previously treat patient unresectable advanced metastatic hepatocellular carcinoma . Patients stratify accord level GPC-3 expression tumor randomize receive either RO5137382 ( 1600 mg intravenously ) placebo Days 1 8 Cycle 1 every 2 week thereafter . Anticipated time study treatment disease progression unacceptable toxicity occur .</brief_summary>
	<brief_title>A Study RO5137382 ( GC33 ) Patients With Advanced Metastatic Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Histologically confirm hepatocellular carcinoma ( without fibrolamellar subtype ) Prior treatment least 1 systemic agent , document progressive disease systemic agent ( ) , document adverse event ( ) associate prior systemic agent ( ) result discontinuance ( ) agent ( ) Not candidate curative treatment ( e.g . resection , transplantation ) ChildPugh A ( score 56 ) Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Adequate hematologic , hepatic renal function Ability provide , central review , tumor tissue sample determine level GPC3 expression IHC Measurable disease RECIST criterion Child Pugh B C Known hepatocellular carcinoma fibrolamellar histology Known brain leptomeningeal metastasis Active infectious disease require treatment except hepatitis B C History organ allograft include liver transplant Anticipated ongoing administration anticancer therapy administer study Anticancer treatment within 2 week prior enter study Patients fully recovered toxicity associate previous HCC locoregional systemic therapy Patients receive interferon therapy Pregnant lactate woman Known HIV positivity AIDSrelated illness History significant hypersensitivity similar agent ( monoclonal antibody , proteinincluded drug , Chinese hamster ovary product )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>